UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

PloS one, 2020-11, Vol.15 (11), p.e0242359

2020

Link zum Volltext

Verfügbarkeit prüfen

Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis

Emerging infectious diseases, 2017-10, Vol.23 (10), p.1711-1713

2017

Link zum Volltext

Verfügbarkeit prüfen

A case report of a child with probable drug resistant tuberculous pericarditis with a review of challenges involved in diagnosis, treatment and follow up of children with DR-TB pericarditis

BMC infectious diseases, 2020-04, Vol.20 (1), p.298-298, Article 298

2020

Link zum Volltext

Verfügbarkeit prüfen

Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

BMC infectious diseases, 2020-09, Vol.20 (1), p.1-675, Article 675

2020

Link zum Volltext

Verfügbarkeit prüfen

Programme costs of longer and shorter tuberculosis drug regimens and drug import: a modelling study for Karakalpakstan, Uzbekistan

ERJ open research, 2022-01, Vol.8 (1), p.622

2022

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with time to sputum culture conversion of rifampicin-resistant tuberculosis patients in Klaipeda, Lithuania in 2016-2019: a cohort study

Monaldi archives for chest disease, 2021-01, Vol.91 (1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis

Emerging infectious diseases, 2019-03, Vol.25 (3), p.441-450

2019

Link zum Volltext

Verfügbarkeit prüfen

The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan

PLOS global public health, 2022, Vol.2 (8), p.e0000567-e0000567

2022

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort study

Monaldi archives for chest disease, 2021-01, Vol.91 (1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Ebola management centre proximity associated with reduced delays of healthcare of Ebola Virus Disease (EVD) patients, Tonkolili, Sierra Leone, 2014-15

PloS one, 2017-05, Vol.12 (5), p.e0176692-e0176692

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Rifampicin-Resistant Tuberculosis Disease and Infection in Children: Key Updates, Challenges and Opportunities

Pathogens (Basel), 2022-03, Vol.11 (4), p.381

2022

Link zum Volltext

Verfügbarkeit prüfen

Detection of Mycobacterium tuberculosis Complex Using the Xpert MTB/RIF Ultra Assay on the Stool of Pediatric Patients in Dushanbe, Tajikistan

Microbiology spectrum, 2023-02, Vol.11 (1), p.e0369822-e0369822

2023

Link zum Volltext

Verfügbarkeit prüfen

Inpatient signs and symptoms and factors associated with death in children aged 5 years and younger admitted to two Ebola management centres in Sierra Leone, 2014: a retrospective cohort study

The Lancet global health, 2016-07, Vol.4 (7), p.e495-e501

2016

Link zum Volltext

Verfügbarkeit prüfen

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen

Emerging infectious diseases, 2015-11, Vol.21 (11), p.2105-2106

2015

Link zum Volltext

Verfügbarkeit prüfen

Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

ERJ open research, 2021, Vol.7 (1), p.537

2021

Link zum Volltext

Verfügbarkeit prüfen

Electronic medical records in humanitarian emergencies - the development of an Ebola clinical information and patient management system [version 3; peer review: 2 approved]

F1000 research, 2016-01, Vol.5, p.1477-1477

2016

Link zum Volltext

Verfügbarkeit prüfen

Costs and import costs of past, present, and future TB drug regimens: a case study for Karakalpakstan, Uzbekistan

Journal of public health (Oxford, England), 2023-06, Vol.45 (2), p.481-487

2023

Link zum Volltext

Verfügbarkeit prüfen

WHO recommendations for multidrug-resistant tuberculosis

The Lancet (British edition), 2016-11, Vol.388 (10057), p.2234-2234

2016

Link zum Volltext

Verfügbarkeit prüfen

Correction: The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan

PLOS global public health, 2024, Vol.4 (4), p.e0003108-e0003108

2024

Link zum Volltext

Verfügbarkeit prüfen

Correction: The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan

PLOS global public health, 2024-01, Vol.4 (4), p.e0003108

2024

Link zum Volltext

Verfügbarkeit prüfen

Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing

The European respiratory journal, 2023-11, Vol.62 (5), p.2300969

2023

Link zum Volltext

Verfügbarkeit prüfen

Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

The European respiratory journal, 2020-03, Vol.55 (3), p.1901467

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis

PLoS medicine, 2018-07, Vol.15 (7), p.e1002591

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(35)
Berichte
(1)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(23)
Humans
(16)
Tuberculosis
(15)
Medicin Och Hälsovetenskap
(12)
Male
(10)
Adolescent
(9)
Antitubercular Agents - Therapeutic Use
(8)
Infectious Diseases
(8)
Tuberculosis, Multidrug-Resistant - Drug Therapy
(8)
Child
(7)
Drug Resistance
(7)
Female
(7)
Child, Preschool
(6)
Drug Therapy
(6)
Patients
(6)
Respiratory System
(6)
Rifampin
(6)
Adult
(5)
Immunology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis

A case report of a child with probable drug resistant tuberculous pericarditis with a review of challenges involved in diagnosis, treatment and follow up of children with DR-TB pericarditis

Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

Programme costs of longer and shorter tuberculosis drug regimens and drug import: a modelling study for Karakalpakstan, Uzbekistan

Factors associated with time to sputum culture conversion of rifampicin-resistant tuberculosis patients in Klaipeda, Lithuania in 2016-2019: a cohort study

Prognostic Indicators for Ebola Patient Survival

Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis

The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan

Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort study

Ebola management centre proximity associated with reduced delays of healthcare of Ebola Virus Disease (EVD) patients, Tonkolili, Sierra Leone, 2014-15

Treatment of Rifampicin-Resistant Tuberculosis Disease and Infection in Children: Key Updates, Challenges and Opportunities

Detection of Mycobacterium tuberculosis Complex Using the Xpert MTB/RIF Ultra Assay on the Stool of Pediatric Patients in Dushanbe, Tajikistan

Inpatient signs and symptoms and factors associated with death in children aged 5 years and younger admitted to two Ebola management centres in Sierra Leone, 2014: a retrospective cohort study

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen

Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effective

Electronic medical records in humanitarian emergencies - the development of an Ebola clinical information and patient management system [version 3; peer review: 2 approved]

Costs and import costs of past, present, and future TB drug regimens: a case study for Karakalpakstan, Uzbekistan

WHO recommendations for multidrug-resistant tuberculosis

Correction: The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan

Correction: The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan

Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing

Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis

Suchergebnisse filtern